A study conducted an evaluation of IRF8 expression in CHL (74 cases), NLPHL (seven cases), ALK-negative anaplastic large cell lymphoma (ALCL) (15 cases), and ALK-positive ALCL (four cases). The gene discussed is IRF8; the disease is classic Hodgkin lymphoma.